# The Benefit of Prophylactic Anticonvulsant in Post Cardiac Arrest Syndrome With Induced Mild Hypothermia

> **NCT01083784** · PHASE4 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Cardiac Arrest

## Interventions

- **DRUG:** Use of prophylactic anticonvulsants (valproate, clonazepam)
- **DRUG:** Control group

## Key facts

- **NCT ID:** NCT01083784
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-03
- **Primary completion:** 2012-12
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01083784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01083784, "The Benefit of Prophylactic Anticonvulsant in Post Cardiac Arrest Syndrome With Induced Mild Hypothermia". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01083784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*